SEBI Reg. Investment Advisor

Download App

Help Center Pricing

Recent:

BSE Healthcare Companies

BSE Sensex 74243.34
116.67 (-0.16%)

The BSE Healthcare Index is designed to reflect the behaviour and performance of mid market capitalization companies. S&P BSE Mid Cap includes all companies forming part of mid cap universe on BSE. Look for Green and Orange companies for investing. Bookmark this page for your easy reference in future.

See MoneyWorks4me's rating on Quality, Valuation, Price Trend and Overall Rating to take informed stock investing decisions. Decizen :- Q: Quality, V: Valuation, PT: Price Trend

Filter

BSE Healthcare companies as on Jun-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

	Company Name	DeciZen	CMP	Price Change (%)	Market Cap (Cr)	52Week High	52Week Low	ROE(%)	P/E	P/BV	EV/ EBITDA	5Y Sales Gr.(%)	5Y Profit Gr.(%)
1	Vimta Labs Ltd	Q V+ PT	544	6.30%	2,286 Small Cap	903 05 Sep, 25	377 30 Mar, 26	18.29	29.49	5.08	14.78	14.27	28.52	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
2	Fermenta Biotech Ltd	Q V PT	337	5.43%	940 Small Cap	399 14 Jul, 25	256 05 Dec, 25	19.19	14.63	2.22	8.99	7.46	0.93	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
3	Acutaas Chemicals Ltd	Q V+ PT	3,328	5.20%	25,903 Small Cap	3,328 05 Jun, 26	1,059 26 Jun, 25	15.50	70.74	15.53	48.71	32.80	16.82	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
4	Kopran Ltd	Q V PT	192	4.81%	884 Small Cap	219 29 May, 26	107 30 Mar, 26	5.88	29.07	1.97	18.72	8.61	14.34	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
5	SMS Pharmaceuticals Ltd	Q V+ PT	369	4.23%	3,313 Small Cap	447 15 Apr, 26	208 07 Aug, 25	10.42	37.82	4.12	20.26	13.70	14.47	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
6	Panacea Biotec Ltd	Q V+ PT	541	3.96%	3,188 Small Cap	541 05 Jun, 26	293 30 Mar, 26	-4.99	0.00	11.18	17225.51	-8.75	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
7	Gufic Biosciences Ltd	Q V PT	370	3.65%	3,576 Small Cap	409 01 Aug, 25	268 30 Mar, 26	12.60	56.62	5.38	25.41	16.69	24.75	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
8	Krishna Institute of Medical Sciences Ltd	Q V+ PT	790	3.27%	30,599 Small Cap	798 24 Jul, 25	576 27 Jan, 26	14.20	117.37	12.60	61.05	11.87	17.04	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
9	Fortis Healthcare Ltd	Q V+ PT	969	3.13%	70,951 Mid Cap	1,105 13 Oct, 25	739 05 Jun, 25	1.59	308.03	7.69	129.69	15.55	-22.45	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
10	Novartis India Ltd	Q V+ PT	1,389	2.79%	3,336 Small Cap	1,588 01 Jun, 26	750 21 Jan, 26	13.21	35.80	4.08	20.08	-4.06	54.56	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
11	Viyash Scientific Ltd	Q V PT	255	2.39%	10,887 Small Cap	277 27 May, 26	166 04 Aug, 25	3.92	61.41	3.74	15.88	5.64	-18.41	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
12	Hester Biosciences Ltd	Q V+ PT	1,964	2.33%	1,633 Small Cap	2,348 04 Aug, 25	1,251 01 Apr, 26	9.68	31.34	4.24	21.26	11.08	0.75	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
13	Gland Pharma Ltd	Q V PT	2,272	2.31%	36,636 Small Cap	2,391 25 May, 26	1,575 16 Mar, 26	11.53	28.19	3.39	17.01	9.35	7.37	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
14	Sai Life Sciences Ltd	Q V+ PT	1,186	2.26%	24,604 Small Cap	1,186 05 Jun, 26	704 13 Jun, 25	10.13	72.05	9.81	37.89	17.75	11.20	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
15	Nephrocare Health Services Ltd	Q V+ PT	676	2.24%	6,636 Small Cap	676 05 Jun, 26	445 19 Dec, 25	7.15	0.00	6.83	61.90	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
16	Anthem Biosciences Ltd	Q V PT	762	2.20%	41,989 Mid Cap	873 18 Sep, 25	579 02 Feb, 26	22.76	62.62	13.18	40.42	23.81	40.64	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
17	Aster DM Healthcare Ltd	Q V+ PT	754	2.02%	38,271 Small Cap	776 21 May, 26	520 04 Feb, 26	7.55	98.60	8.36	36.67	-13.71	0.61	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
18	Shilpa Medicare Ltd	Q V+ PT	537	2.02%	10,290 Small Cap	537 05 Jun, 26	260 27 Jan, 26	4.25	42.29	3.97	24.52	7.22	-12.54	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
19	Torrent Pharmaceuticals Ltd	Q V+ PT	4,419	1.87%	1,46,806 Large Cap	4,715 25 May, 26	3,134 06 Jun, 25	29.04	67.86	17.50	35.93	11.80	13.74	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
20	JB Chemicals & Pharmaceuticals Ltd	Q V+ PT	2,170	1.78%	34,226 Small Cap	2,285 25 May, 26	1,603 06 Oct, 25	17.99	50.77	8.48	30.75	15.51	9.89	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
21	Sigachi Industries Ltd	Q V+ PT	21.56	1.65%	810 Small Cap	59.50 16 Jun, 25	16.74 30 Mar, 26	9.61	0.00	1.70	15.32	24.05	7.49	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
22	Wanbury Ltd	Q V+ PT	262	1.53%	902 Small Cap	329 16 Jun, 25	162 27 Jan, 26	69.35	13.64	6.25	10.31	10.29	30.27	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
23	Strides Pharma Science Ltd	Q V+ PT	1,043	1.52%	9,469 Small Cap	1,231 12 May, 26	770 29 Jan, 26	1.56	51.57	2.88	25.92	4.81	-16.98	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
24	Krsnaa Diagnostics Ltd	Q V+ PT	551	1.47%	1,762 Small Cap	892 24 Sep, 25	502 30 Mar, 26	8.79	17.37	1.80	7.41	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
25	Ipca Laboratories Ltd	Q V+ PT	1,643	1.43%	41,098 Mid Cap	1,679 20 May, 26	1,253 24 Oct, 25	12.48	36.29	5.15	21.85	8.87	4.68	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
26	Laurus Labs Ltd	Q V+ PT	1,447	1.39%	77,104 Mid Cap	1,447 05 Jun, 26	623 05 Jun, 25	7.37	86.75	14.54	43.32	14.42	4.11	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
27	Cohance Lifesciences Ltd	Q V+ PT	431	1.32%	16,272 Small Cap	1,121 17 Jul, 25	268 09 Mar, 26	13.87	90.79	4.16	35.53	7.51	-3.15	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
28	Vijaya Diagnostic Centre Ltd	Q V+ PT	1,378	1.31%	13,992 Small Cap	1,380 04 Jun, 26	848 30 Mar, 26	19.78	80.89	14.62	38.97	15.00	18.43	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
29	Sanofi Consumer Healthcare India Ltd	Q V+ PT	4,771	1.29%	10,847 Small Cap	5,954 30 Jun, 25	3,951 02 Mar, 26	83.57	42.06	24.01	29.70	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
30	CORONA Remedies Ltd	Q V+ PT	1,723	1.22%	10,409 Small Cap	1,951 12 May, 26	1,337 23 Dec, 25	27.46	56.31	13.95	34.56	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
31	Astrazeneca Pharma India Ltd	Q V+ PT	8,599	1.20%	21,243 Small Cap	10,653 13 Jun, 25	7,630 06 Apr, 26	24.76	113.28	24.34	71.58	15.59	20.47	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
32	Max Healthcare Institute Ltd	Q V PT	977	1.12%	94,040 Mid Cap	1,314 04 Jul, 25	904 07 Apr, 26	12.68	65.20	8.75	40.01	46.01	60.18	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
33	Narayana Hrudayalaya Ltd	Q V PT	1,970	1.09%	39,828 Mid Cap	2,372 27 Jun, 25	1,564 30 Mar, 26	24.16	49.44	8.78	24.79	11.88	45.85	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
34	Ajanta Pharma Ltd	Q V PT	2,978	1.02%	36,827 Mid Cap	3,315 19 May, 26	2,335 30 Sep, 25	24.45	34.87	8.13	23.57	12.43	17.07	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
35	Indegene Ltd	Q V+ PT	523	0.99%	12,471 Small Cap	620 12 Jun, 25	415 23 Mar, 26	19.78	31.09	3.97	17.50	34.59	31.10	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
36	Poly Medicure Ltd	Q V PT	1,420	0.95%	14,255 Small Cap	2,318 02 Jul, 25	1,184 30 Mar, 26	15.04	42.43	4.67	25.55	19.91	26.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
37	Emcure Pharmaceuticals Ltd	Q V PT	1,761	0.91%	33,090 Small Cap	1,830 05 May, 26	1,230 07 Jul, 25	11.03	45.15	8.92	25.81	13.02	9.98	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
38	Health X Platform Ltd	Q V PT	304	0.91%	958 Small Cap	375 13 Jan, 26	253 30 Mar, 26	-0.26	0.00	3.54	-1199.26	109.54	-201.92	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
39	Lupin Ltd	Q V PT	2,268	0.86%	1,02,818 Mid Cap	2,492 07 May, 26	1,839 06 Aug, 25	20.83	19.28	4.58	11.15	8.11	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
40	Dr. Reddys Laboratories Ltd	Q V PT	1,278	0.85%	1,05,755 Mid Cap	1,378 12 Jun, 25	1,149 21 Jan, 26	17.66	25.20	2.79	13.91	13.26	22.29	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
41	Orchid Pharma Ltd	Q V PT	841	0.84%	4,232 Small Cap	898 26 Nov, 25	471 30 Mar, 26	8.04	93.61	3.09	43.20	13.89	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
42	Caplin Point Laboratories Ltd	Q V PT	2,031	0.83%	15,314 Small Cap	2,397 17 Sep, 25	1,502 30 Mar, 26	20.20	23.88	4.27	16.77	17.55	21.52	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
43	Lincoln Pharmaceuticals Ltd	Q V PT	625	0.83%	1,242 Small Cap	770 27 May, 26	440 04 Feb, 26	11.86	14.13	1.64	9.26	10.63	11.62	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
44	Pfizer Ltd	Q V PT	4,455	0.80%	20,220 Small Cap	5,988 16 Jun, 25	4,413 04 Jun, 26	16.58	27.99	4.81	15.67	1.18	5.79	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
45	Global Health Ltd	Q V PT	1,240	0.78%	33,068 Small Cap	1,456 08 Aug, 25	955 30 Mar, 26	15.18	66.64	8.22	37.68	16.83	34.86	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
46	Abbott India Ltd	Q V PT	26,018	0.71%	54,896 Mid Cap	35,922 03 Jul, 25	25,164 27 Apr, 26	35.71	35.37	11.50	24.14	9.38	18.78	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
47	Apollo Hospitals Enterprise Ltd	Q V+ PT	8,304	0.66%	1,18,612 Large Cap	8,490 25 May, 26	6,680 28 Jan, 26	15.77	79.47	11.90	44.48	-3.49	29.94	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
48	RPG Life Sciences Ltd	Q V+ PT	2,164	0.64%	3,556 Small Cap	2,716 07 Jul, 25	1,731 23 Mar, 26	27.50	30.88	5.87	19.80	11.71	30.85	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
49	Aarti Drugs Ltd	Q V+ PT	377	0.55%	3,423 Small Cap	575 21 Jul, 25	319 30 Mar, 26	12.69	17.56	2.21	12.80	5.74	4.42	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
50	Gujarat Themis Biosyn Ltd	Q V+ PT	413	0.46%	4,484 Small Cap	479 27 Oct, 25	226 30 Mar, 26	21.67	96.06	15.58	59.50	12.12	15.55	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Vimta Labs	543.95	6.30%
Fermenta Biotech	336.90	5.43%
Acutaas Chemicals	3,328.40	5.20%
Kopran	191.85	4.81%
SMS Pharmaceuticals	368.75	4.23%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
Suven Life Sciences	237.15	-10.98%
Wockhardt	1,920.15	-7.37%
Rubicon Research	1,202.15	-7.29%
FDC	380.75	-5.04%
Bliss GVS Pharma	438.05	-4.12%

News about BSE Healthcare

Jun, 2026

SMS Pharmaceuticals informs about disclosure

SMS Pharmaceuticals has informed that the Company had received a request from a shareholder holding shares in physical form for updating KYC documents through the Registrar and Share Transfer Agent (RTA) of the Company. Upon verification of the KYC documents submitted by the shareholder, the Company observed that the said shares had already been claimed by another person impersonating the original shareholder. Accordingly, the Company initiated a detailed enquiry and carried out verification of the documents and transfer records relating to the said shares.

The above information is a part of company’s filings submitted to BSE.

Jun, 2026

Fortis Healthcare informs about updates

In terms of SEBI Circular No. SEBI/HO/MIRSD/MIRSD-PoD/P/CIR/2025/97 dated July 2, 2025 and HO/38/13/11(2)2026-MIRSD-POD/I/3750/2026 dated January 30, 2026, Fortis Healthcare has enclosed report dated June 4, 2026 received from the Registrar and Share Transfer Agent of the Company i.e., KFin Technologies on the status of re-lodgement of transfer requests of physical shares for the month ended on March 31, 2026 and April 30, 2026.

The above information is a part of company’s filings submitted to BSE.

Jun, 2026

Gujarat Themis Biosyn informs about outcome of postal ballot

Pursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Gujarat Themis Biosyn has enclosed Voting Results of the business transacted by the Company by way of Postal Ballot; and Scrutinizer’s Report dated 4th June, 2026 on the Postal Ballot. The resolution as proposed in the Postal Ballot Notice has been passed by the shareholders by remote e-voting process with requisite majority. The Voting Results along with the Scrutinizer’s Report will also be made available on the Company’s website at www.gtbl.in

The above information is a part of company’s filings submitted to BSE.

Jun, 2026

Nephrocare Health jumps as its arm inks asset transfer pact with Inocentes Dialysis Clinic

The agreement is for the acquisition of identified assets relating to a dialysis center located at Duyan-Duyan, Project 3, Quezon City, Philippines

Jun, 2026

Lupin soars on getting UDFDA approval for Ranluspec (ranibizumab) injection

Ranluspec is the only interchangeable biosimilar ranibizumab approved in the United States in both vials and PFS

Jun, 2026

Lupin gets UDFDA approval for Ranluspec (ranibizumab) injection

Ranluspec is the only interchangeable biosimilar ranibizumab approved in the United States in both vials and PFS

Track Now:

5 Star Companies Large Cap Companies Mid Cap Companies Small Cap Companies Nifty Microcap Companies Top IT Companies Tax saver funds Analyze your Equity Funds Nifty Index Funds

BSE Healthcare FAQs

You can use different criterias to arrive at the list of best stocks in the BSE Healthcare company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the BSE Healthcare companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Sun Pharma Advanced Research Company Ltd. (S)	Not Good	212	6,909	4.45	5.18	4.64	720
Sanofi Consumer Healthcare India Ltd. (S)	Not Good	4,771	10,847	42.06	24.01	29.70	83.57
Wanbury Ltd. (S)	Very Good	262	902	13.64	6.25	10.31	69.35
Glaxosmithkline Pharmaceuticals Ltd. (M)	Very Good	2,166	36,702	35.43	16.19	24.28	47.10
Procter & Gamble Health Ltd. (S)	Very Good	6,172	10,292	31.48	19.62	21.32	43.64

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	1,447	77,104	126
Sai Life Sciences Ltd. (S)	Very Good	1,186	24,604	62.08
Granules India Ltd. (S)	Very Good	790	19,600	47.89
Neuland Laboratories Ltd. (S)	Somewhat Good	16,813	21,640	43.04
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,419	1,46,806	40.55
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
Health X Platform Ltd. (S)	Not Good	304	958	0.00	3.54	-1199.26	110
Fischer Medical Ventures Ltd. (S)	Not Good	33.47	2,205	0.00	7.06	-428.39	96.10
3B Blackbio Dx Ltd. (S)	Somewhat Good	1,121	970	19.66	3.55	13.22	46.29
Max Healthcare Institute Ltd. (M)	N/A	977	94,040	65.20	8.75	40.01	46.01
Indegene Ltd. (S)	Very Good	523	12,471	31.09	3.97	17.50	34.59

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Yatharth Hospital & Trauma Care Services Ltd. (S)	Very Good	809	7,786	81.61	4.81	47.80	138
3B Blackbio Dx Ltd. (S)	Somewhat Good	1,121	970	19.66	3.55	13.22	132
Neuland Laboratories Ltd. (S)	Somewhat Good	16,813	21,640	59.60	11.60	35.60	64.99
Max Healthcare Institute Ltd. (M)	N/A	977	94,040	65.20	8.75	40.01	60.18
Novartis India Ltd. (S)	Somewhat Good	1,389	3,336	35.80	4.08	20.08	54.56

You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

BSE Healthcare Companies

News about BSE Healthcare

SMS Pharmaceuticals informs about disclosure

Fortis Healthcare informs about updates

Gujarat Themis Biosyn informs about outcome of postal ballot

Nephrocare Health jumps as its arm inks asset transfer pact with Inocentes Dialysis Clinic

Lupin soars on getting UDFDA approval for Ranluspec (ranibizumab) injection

Lupin gets UDFDA approval for Ranluspec (ranibizumab) injection

Track Now:

Trending Blogs

BSE Healthcare FAQs

How to select the top BSE Healthcare stocks based on RoE?

What are the best-performing stocks in the BSE Healthcare index?

Which BSE Healthcare stocks have the highest revenue growth in the past five years?

Which BSE Healthcare stocks had the highest profit growth in the past five years ?

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.